高盛-爱博医疗(688050.SS)业绩分析:2026年三季报收入符合预期,净利润略低于预期;下调目标价至人民币48元;中性-AIBO Medical(688050.SS):Performance Analysis:3Q26 Revenue In Line With Expectations,Net Profit Slightly Below Expect-20261028【6页】

发表回复

后才能评论